Evidence map›Paper›PMID 23978451›Full record

Trial reportProstaglandins, leukotrienes, and essential fatty acids2013

Flaxseed enriched diet-mediated reduction in ovarian cancer severity is correlated to the reduction of prostaglandin E(2) in laying hen ovaries.

Erfan Eilati, Karen Hales, Yan Zhuge, Kristine Ansenberger Fricano, Rui Yu, Richard B van Breemen, Dale Buchanan Hales

Abstract readRandomized Controlled Trial
In one paragraph

Trial report in Prostaglandins, leukotrienes, and essential fatty acids, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed
1.1field-weighted citation impact, top 23% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed, 23 citations in OpenAlex.

  1. Review
  2. Article
  3. Review
  4. Review
  5. Article
  6. Review
  7. Article
  8. Article
  9. Flaxseed and its components differentially affect estrogen targets in pre-neoplastic hen ovaries.The Journal of steroid biochemistry and molecular biology · 2016
    Article
  10. Article
  11. The promise and challenge of ovarian cancer models.Translational cancer research · 2015
    Article
  12. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 2 institutions in 1 country.

Erfan EilatiDepartment of Physiology, Southern Illinois University at Carbondale, School of Medicine, Carbondale, IL, USA.
Karen Hales
Yan Zhuge
Kristine Ansenberger Fricano
Rui Yu
Richard B van Breemen
Dale Buchanan Hales
University of Illinois Chicago · USSouthern Illinois University Carbondale · US

Funding

Therapeutic Efficacy of Flaxseed in the Treatment of Ovarian CancerR01AT005295 · NCCIH · SOUTHERN ILLINOIS UNIVERSITY CARBONDALE · PI HALES, DALE B · 2011 to 2015
$1.8M
Therapeutic Efficacy of Flax Seed in the Prevention of Ovarian CancerR21AT004085 · NCCIH · UNIVERSITY OF ILLINOIS AT CHICAGO · PI HALES, DALE B · 2007 to 2008
$425k
Dietary Intervention in the Gallus Domesticus Model of Ovarian CancerR03CA133915 · NCI · UNIVERSITY OF ILLINOIS AT CHICAGO · PI HALES, DALE B · 2008 to 2009
$160k
NCCIH NIH HHS AT004085NCCIH NIH HHS AT005295NCCIH NIH HHS R01 AT005295NCCIH NIH HHS R21 AT004085NCI NIH HHS CA133915NCI NIH HHS R03 CA133915
6 · The paper itself

Abstract

Prevention of ovarian cancer is the best approach for reducing the impact of this deadly disease. The laying hen is a robust model of spontaneous ovarian cancer that recapitulates the human disease. Dietary intervention with flaxseed, the richest vegetable source of omega-3 fatty acids (OM-3FAs) and phytoestrogen lignans, demonstrate the potential for effective prevention and amelioration of ovarian cancer by targeting inflammatory prostaglandin pathways. Prostaglandin E2 (PGE2) is the most pro-inflammatory ecoisanoid and one of the downstream products of two isoforms of cyclooxygenase (COX) enzymes: COX-1 and COX-2. Our objective was to investigate the effect of flaxseed supplementation for one year on ovarian cancer and correlate its effects to expression of COX enzymes and concentrations of prostaglandins. White Leghorn hens were fed 10% flaxseed-enriched or standard diet for one year. The severity of ovarian cancer was determined by gross pathology and histology. COX-1 and COX-2 localization and protein and mRNA expression and PGE2 and PGE3 concentrations in ovaries were measured by IHC, western blot, quantitative real-time PCR and LC-MS-MS, respectively. The results demonstrated a significant reduction in late stage ovarian tumors in the flaxseed-fed hens compared with the control diet-fed hens. In correlation with decreased ovarian cancer severity, concentrations of PGE2 and expression of COX-2 were diminished in ovaries of flaxseed-fed hens. PGE3 concentrations were below the level of detection. The results demonstrated that in normal ovaries, COX-1 was localized to the granulosa cell layer surrounding the follicles and ovarian surface epithelium (OSE) whereas COX-2 protein was localized to the granulosa cell layer in the follicle. Extensive COX-1 and COX-2 protein expression was found throughout the ovarian carcinoma. Our findings suggest that the flaxseed-mediated reduction in the severity of ovarian cancer in hens is correlated to the reduction in PGE2 in the ovaries of flaxseed-fed hens. These findings may provide the basis for clinical trials of dietary intervention targeting prostaglandin biosynthesis for the prevention and treatment of ovarian cancer.

Indexed as

FlaxAnimal FeedAnimalsAvian ProteinsChickensCyclooxygenase 1Cyclooxygenase 2DietDietary SupplementsDinoprostoneFatty Acids, Omega-3FemaleGene ExpressionHumansOvarian NeoplasmsOvaryAvian ProteinsCyclooxygenase 1Cyclooxygenase 2DinoprostoneFatty Acids, Omega-3Receptors, Prostaglandin E, EP4 SubtypeCyclooxygenasesFlaxseedLaying henOvarian cancerProstaglandin E(2)

Identifiers

PMID23978451
PMCPMC3811136
OpenAlexW2107689079

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.